title: [Tolerance profile of platinum compounds].
authors.affiliation: Oncologia Medica, Azienda Ospedaliera, Parma.
authors.forename: S
authors.initials: S
authors.lastname: Cascinu
authors.forename: S
authors.initials: S
authors.lastname: Munaó
authors.forename: M
authors.initials: M
authors.lastname: Mare
authors.forename: P
authors.initials: P
authors.lastname: Amadio
authors.forename: E
authors.initials: E
authors.lastname: Crucitta
authors.forename: G
authors.initials: G
authors.lastname: Picone
mesh_terms: D016190:Carboplatin / Q000009:adverse effects / Q000627:therapeutic use; D002945:Cisplatin / Q000009:adverse effects / Q000627:therapeutic use; D005440:Fluid Therapy; D006801:Humans; D009944:Organoplatinum Compounds / Q000009:adverse effects / Q000627:therapeutic use; D000077150:Oxaliplatin; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D017671:Platinum Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D051437:Renal Insufficiency / Q000139:chemically induced / Q000517:prevention & control
chemical_list: D009944:Organoplatinum Compounds; D017671:Platinum Compounds; D000077150:Oxaliplatin; D016190:Carboplatin; D002945:Cisplatin; C049777:ormaplatin